Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Affective Disorders
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2529411537
